Editorial: Engineered Targeted Cancer Immunotherapies by Massimo Fantini, Roberto Bei

Get full text

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy by Massimo Fantini, Philip Martin Arlen, Kwong Yok Tsang

Get full text

840 A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) can also identify immunosuppressive regulatory T (Tregs) cells and down regulate Treg-mediated immunosuppressio... by Kwong Tsang, Massimo Fantini, Christopher Cole, Christina Annunziata, Philip Arlen

The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation by Chiara Amoroso, Federica Perillo, Francesco Strati, Massimo Fantini, Flavio Caprioli, Federica Facciotti

Get full text

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas by Kwong yok Tsang, Massimo Fantini, Sharon A. Mavroukakis, Anjum Zaki, Christina M. Annunziata, Philip M. Arlen

Get full text

Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201 by Kwong Y. Tsang, Massimo Fantini, Anjum Zaki, Sharon A. Mavroukakis, Maria Pia Morelli, Christina M. Annunziata, Philip M. Arlen

Get full text

PB1993: EXPRESSION OF NEO-201 MAY HELP IN THE DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA by Andrea Duminuco, Kwong Tsang, Nunziatina Laura Parrinello, Sara Marino, Loredana Villari, Massimo Fantini, Giuseppe Palumbo, Francesco DI Raimondo, Philip Arlen, Alessandra Romano

Get full text

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas by Massimo Fantini, Justin M. David, Olga Saric, Alexander Dubeykovskiy, Yongzhi Cui, Sharon A. Mavroukakis, Andrew Bristol, Christina M. Annunziata, Kwong Y. Tsang, Philip M. Arlen

Get full text

879 Post-treatment neutrophil-to-lymphocyte ratio and gMDSCs as independent prognostic factors for treatment efficacy with monoclonal antibody NEO-201 and pembrolizumab by Massimo Fantini, Kwong Y Tsang, Christina Annunziata, Philip Arlen, Anjum Zaki, Sharon Mavroukakis, Charalampos S Floudas, Jamie Hur, Azam Ghafoor, Ann McCoy, Erica Redmond, Christine Feierabend

Co-circulation of Dengue and Chikungunya Viruses, Al Hudaydah, Yemen, 2012 by Giovanni Rezza, Gamal El-Sawaf, Giovanni Faggioni, Fenicia Vescio, Ranya Al Ameri, Riccardo De Santis, Ghada Helaly, Alice Pomponi, Dalia Metwally, Massimo Fantini, Hussein Qadi, Massimo Ciccozzi, Florigio Lista

Get full text

Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types by Kristin C. Hicks, Massimo Fantini, Renee N. Donahue, Angie Schwab, Karin M. Knudson, Sarah R. Tritsch, Caroline Jochems, Paul E. Clavijo, Clint T. Allen, James W. Hodge, Kwong Y. Tsang, Jeffrey Schlom, Sofia R. Gameiro

Get full text

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer by Kristen P. Zeligs, Maria Pia Morelli, Justin M. David, Monica Neuman, Lidia Hernandez, Stephen Hewitt, Michelle Ozaki, Akosua Osei-Tutu, David Anderson, Thorkell Andresson, Sudipto Das, Justin Lack, Justin Lack, Abdalla Abdelmaksoud, Abdalla Abdelmaksoud, Massimo Fantini, Philip M. Arlen, Kwong Y. Tsang, Christina M. Annunziata

Get full text

First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors by Christopher B. Cole, Maria Pia Morelli, Massimo Fantini, Markku Miettinen, Patricia Fetsch, Cody Peer, William D. Figg, Tyler Yin, Nicole Houston, Ann McCoy, Stanley Lipkowitz, Alexandra Zimmer, Jung-min Lee, Miroslava Pavelova, Erin N. Villanueva, Kathryn Trewhitt, B. Brooke Solarz, Maria Fergusson, Sharon A. Mavroukakis, Anjum Zaki, Kwong Y. Tsang, Philip M. Arlen, Christina M. Annunziata

Get full text

Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors by Christopher B. Cole, Maria Pia Morelli, Massimo Fantini, Markku Miettinen, Patricia Fetsch, Cody Peer, William D. Figg, Tyler Yin, Nicole Houston, Ann McCoy, Stanley Lipkowitz, Alexandra Zimmer, Jung-min Lee, Miroslava Pavelova, Erin N. Villanueva, Kathryn Trewhitt, B. Brooke Solarz, Maria Fergusson, Sharon A. Mavroukakis, Anjum Zaki, Kwong Y. Tsang, Philip M. Arlen, Christina M. Annunziata

Get full text